The Valley Desk

NCT00820222 · Interventional trial

Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer

Overall registry status Completed

Phase 3

Conditions Metastases, Brain

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov